ARM-210

DB16944InvestigationalSmall molecule

ARM-210: Overview.

Mechanism: Pharmacologically active on Ryanodine receptor 1 and Ryanodine receptor 2
Curator reviewed
Formula / weight: C₁₈H₁₉NO₃S · 329.41 g/mol (avg)
Also known as: 4-((7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5h)-yl)methyl)benzoic acid · Benzoic acid, 4-((2,3-dihydro-7-methoxy-1,4-benzothiazepin-4(5h)-yl)methyl)- · Rycal dmd
Code names: ARM-210 · S-48168

Resolves to

Compound

Structure

InChIKeyJIGDAUOKKYKRKO-UHFFFAOYSA-NSMILESCOC1=CC=C2SCCN(CC3=CC=C(C=C3)C(O)=O)CC2=C1

Targets

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with ARM-210, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.